BMJ supportive & palliative care · 2026
Nutritional status and paediatric anthracycline early cardiotoxicity.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mande Radnyi, Prasad Maya, Gala Rajul, Parambil Badira C, Mohan Ram, Rane Pallavi, Chinnaswamy Girish
Аннотация
OBJECTIVES: To evaluate the incidence, pattern and risk factors of early cardiotoxicity and to assess the impact of undernutrition in children with Wilms tumour (WT) and hepatoblastoma receiving anthracycline-based therapy.
METHODS: In this retrospective cohort study, 137 children treated between 2017 and 2022 were analysed. Cardiac function was monitored by serial echocardiography, and nutritional status was assessed using WHO and Pediatric Hematology-Oncology Association of Central America (AHOPCA) criteria. Multivariable logistic regression was performed to identify factors associated with early cardiac dysfunction.
RESULTS: The incidence of early cardiotoxicity was 11.7%. Majority of patients who developed cardiotoxicity were asymptomatic. Undernutrition, assessed by WHO and AHOPCA criteria, was highly prevalent and significantly associated with cardiac dysfunction. Most affected patients showed recovery with medical management.
CONCLUSIONS: Undernourished children receiving anthracycline therapy for WT and hepatoblastoma are at increased risk of early cardiotoxicity. Routine nutritional assessment, early intervention and close cardiac monitoring may help mitigate acute cardiac toxicity in this vulnerable population.
METHODS: In this retrospective cohort study, 137 children treated between 2017 and 2022 were analysed. Cardiac function was monitored by serial echocardiography, and nutritional status was assessed using WHO and Pediatric Hematology-Oncology Association of Central America (AHOPCA) criteria. Multivariable logistic regression was performed to identify factors associated with early cardiac dysfunction.
RESULTS: The incidence of early cardiotoxicity was 11.7%. Majority of patients who developed cardiotoxicity were asymptomatic. Undernutrition, assessed by WHO and AHOPCA criteria, was highly prevalent and significantly associated with cardiac dysfunction. Most affected patients showed recovery with medical management.
CONCLUSIONS: Undernourished children receiving anthracycline therapy for WT and hepatoblastoma are at increased risk of early cardiotoxicity. Routine nutritional assessment, early intervention and close cardiac monitoring may help mitigate acute cardiac toxicity in this vulnerable population.